Table 1.

Cancer clinical trials investigating fecal microbiota transplantation (FMT) therapy

Trial no.	Phase	Cancer type	Intervention	Sponsor/investigator
NCT03341143	II	Melanoma	FMT (via colonoscopy) + immune checkpoint inhibitors	UPMC Hillman Cancer Center
NCT03353402	I	Melanoma	FMT (via colonoscopy and stool capsules) + immune checkpoint inhibitors	Sheba Medical Center
NCT03772899	I	Melanoma	FMT + immune checkpoint inhibitors	Lawson Health Research Institute
NCT04577729	–	Melanoma	Autologous or allogeneic FMT + immune checkpoint inhibitors	Medical University of Graz
NCT04521075	I/II	Melanoma NSCLC	FMT (stool capsules) + immune checkpoint inhibitors	Sheba Medical Center
NCT04056026	I	Mesothelioma	FMT (via colonoscopy) + immune checkpoint inhibitors	ProgenaBiome
NCT04116775	II	Prostate	FMT (via endoscopy) + immune checkpoint inhibitors + enzalutamide	VA Portland Health Care System
NCT04130763	I	Gastrointestinal	FMT (stool capsules) + immune checkpoint inhibitors	Peking University

NSCLC, non-small cell lung cancer.